加巴喷丁治疗奥氮平所致不宁腿综合征2例并文献复习

doi:10.3969/j.issn.1004-583X.2023.01.010

摘要/Abstract

摘要：

目的探讨加巴喷丁治疗奥氮平所致不宁腿综合征(restless legs syndrome, RLS)的有效性。方法回顾性分析2例加巴喷丁治疗奥氮平所致RLS患者的临床资料及诊疗经过,并对相关文献进行复习。结果 2例精神分裂症患者均在应用奥氮平治疗期间出现夜间双下肢难以形容的不适,控制不住地想要活动双腿,并起床走动,否则周身不适,难以入睡,用手拍打下肢或下床走动可减轻不适。诊断奥氮平所致RLS,应用加巴喷丁治疗后取得较好疗效。结论加巴喷丁可用于奥氮平所致RLS的治疗。

关键词: 不宁腿综合征, 精神分裂症, 奥氮平, 加巴喷丁

Abstract:

Objective To explore the therapeutic efficacy of gabapentin on olanzapine-induced restless legs syndrome (RLS). Methods The clinical data, diagnosis and treatment of 2 cases of olanzapine-induced RLS treated with gabapentin were analyzed retrospectively, and the related literatures were reviewed. Results During the treatment with olanzapine, two patients with schizophrenia both suffered from unspeakable discomfort in their lower limbs at night. They uncontrollably wanted to move their legs and got up and walked, otherwise they would feel uncomfortable and difficult to fall asleep. Patting with their hands or walking out of bed could alleviate the discomfort. They were diagnosed as olanzapine-induced RLS and successfully treated with gabapentin. Conclusion Gabapentin can be used to treat olanzapine-induced RLS.

Key words: restless legs syndrome, schizophrenia, olanzapine, gabapentin

中图分类号:

R742.89

孙振晓, 赵林. 加巴喷丁治疗奥氮平所致不宁腿综合征2例并文献复习[J]. 临床荟萃, 2023, 38(1): 68-70.

Sun Zhenxiao, Zhao Lin. Gabapentin treatment in olanzapine-induced restless legs syndrome: Two cases report and literature review[J]. Clinical Focus, 2023, 38(1): 68-70.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://huicui.hebmu.edu.cn/CN/10.3969/j.issn.1004-583X.2023.01.010

https://huicui.hebmu.edu.cn/CN/Y2023/V38/I1/68

参考文献 27

[1]	O'Regan D, Anderson KN. Restless legs syndrome and periodic limb movements of sleep[J]. Br J Hosp Med(Lond), 2020, 81(1):1-8.
[2]	Ostroumova TM, Ostroumova OD, Filippova YA, et al. Drug-induced restless legs syndrome[J]. Zh Nevrol Psikhiatr Im S S Korsalova, 2020, 120(4):129-135.
[3]	Japaridze G, Kasradze S, Maisuradze L, et al. The restless legs syndrome(review)[J]. Georgian Med News, 2018, (285):74-81. pmid: 30702074
[4]	Didato G, Giacomo RD, Rosa GJ, et al. Restless legs syndrome across the lifespan: Symptoms, pathophysiology, management and daily life impact of the different patterns of disease presentation[J]. Int J Environ Res Public Health, 2020, 17(10):3658. doi: 10.3390/ijerph17103658 URL
[5]	张海山, 寻广磊. 奥氮平所致不宁腿综合征二例报告[J]. 精神医学杂志, 2012, 25(3):214.
[6]	Zhao M, Geng T, Qiao L, et al. Olanzapine-induced restless legs syndrome[J]. J Clin Neurosci, 2014, 21(9):1622-1625. doi: 10.1016/j.jocn.2014.01.007 pmid: 24874697
[7]	Soyata AZ, Celebi F, Yarge LI. Restless legs syndrome after single low dose quetiapine administration[J]. Curr Drug Saf, 2016, 11(2):172-173. pmid: 26582164
[8]	Rittmannsberger H, Werl R. Restless legs syndrome induced by quetiapine: Report of seven cases and review of the literature[J]. Int J Neuropsychopharmacol, 2013, 16(6):1427-1431. doi: 10.1017/S1461145712001599 pmid: 23331473
[9]	闫冬梅, 裴树景. 喹硫平致不宁腿综合征1例报告[J]. 国际精神病学杂志, 2019, 46(6):1146-1147.
[10]	王海红, 刘晓华, 施慎逊. 氨磺必利致不宁腿综合征一例[J]. 中华精神科杂志, 2020, 53(1):69-70.
[11]	Kumar V, Venkatasubramanian G. Gabapentin treatment in clozapine-induced restless legs syndrome: Two cases and a review of the literature[J]. Ther Adv Psychopharmacol, 2017, 7(1):42-47. doi: 10.1177/2045125316672133 URL
[12]	Duggal HS, Mendhekar DN. Clozapine- associated restless legs syndrome[J]. J Clin Psychopharmacol, 2007, 27(1):89-90. doi: 10.1097/JCP.0b013e31802e7587 URL
[13]	Zhu C, Bi R, Hu Y, et al. Restless legs syndrome following the use of ziprasidone: A case report[J]. Gen Psychiatr, 2020, 33(2):e100112.
[14]	Wetter TC, Brunner J, Bronisch T. Restless legs syndrome probably induced by risperidone treatment[J]. Pharmacopsychiatry, 2002, 35(3):109-111. pmid: 12107855
[15]	Bolaños-Vergaray J, Obaya JC, Gonzalez R, et al. Restless legs syndrome due to aripiprazole[J]. Eur J Clin Pharmacol, 2011, 67(5):539-540. doi: 10.1007/s00228-010-0952-9 pmid: 21104073
[16]	Aggarwal S, Dodd S, Berk M. Restless leg syndrome associated with olanzapine: A case series[J]. Curr Drug Saf, 2010, 5(2):129-131. pmid: 20406161
[17]	Kang SG, Lee HJ, Kim L. Restless legs syndrome and periodic limb movements during sleep probably associated with olanzapine[J]. J Psychopharmacol, 2009, 23(5):597-601. doi: 10.1177/0269881108091876 URL
[18]	Khalid I, Rana L, Khalid TJ, et al. Refractory restless legs syndrome likely caused by olanzapine[J]. J Clin Sleep Med, 2009, 5(1):68-69. pmid: 19317385
[19]	Kraus T, Schuld A, Pollmächer T. Periodic leg movements in sleep and restless legs syndrome probably caused by olanzapine[J]. J Clin Psychopharmacol, 1999, 19(5):478-479. pmid: 10505594
[20]	Allen RP, Picchietti DL, Garcia-Borreguero D, et al. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: Updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance[J]. Sleep Med, 2014, 15(8):860-873. doi: 10.1016/j.sleep.2014.03.025 pmid: 25023924
[21]	张茜, 陈项婷, 周长青. 药物治疗不宁腿综合征有效性和安全性的网状Meta分析[J]. 中国循证医学杂志, 2022, 22(8): 908-916.
[22]	Gonzalez-Latapi P, Malkani R. Update on restless legs syndrome: From mechanisms to treatment[J]. Curr Neurol Neurosci Rep, 2019, 19(8):54. doi: 10.1007/s11910-019-0965-4 URL
[23]	Winkelmann J, Allen RP, Högl B, et al. Treatment of restless legs syndrome: Evidence-based review and implications for clinical practice (Revised 2017)[J]. Mov Disord, 2018, 3(7):1077-1091.
[24]	陈梓斌, 吴原, 刘晓菲, 等. 加巴喷丁治疗不宁腿综合征的系统评价[J]. 中国循证医学杂志, 2012, 12(6):727-734.
[25]	Kumar V, Ambekar N, Singh A, et al. Successful treatment of antipsychotic-induced restless legs syndrome with gabapentin[J]. Asian J Psychiatr, 2014, 9:89-90. doi: 10.1016/j.ajp.2014.01.010 pmid: 24813045
[26]	Kumar V, Venkatasubramanian G. Gabapentin treatment in clozapine-induced restless legs syndrome: Two cases and review of the literature[J]. Ther Adv Psychopharmacol, 2017, 7(1):42-47. doi: 10.1177/2045125316672133 URL
[27]	顾梦阅, 狄东川, 邱俊, 等. 加巴喷丁治疗奥氮平致不宁腿综合征1例[J]. 四川精神卫生, 2021, 34(3):277-279.